Searching for epithalon pharmacie reflects a growing requirement among laboratory investigators for analytical-grade Epithalon (Epitalon) compliant with stringent purity standards. As a synthetic short-chain pineal bioregulator peptide, Epithalon is evaluated in preclinical models for its ability to induce telomerase expression, preserve chromosomal integrity, and regulate neuroendocrine output. PX1 Research provides high-purity research compounds backed by third-party HPLC and mass spectrometry testing strictly for in vitro and laboratory research applications.
Searching for epithalon pharmacie reflects a growing requirement among laboratory investigators for analytical-grade Epithalon (Epitalon) compliant with stringent purity standards. As a synthetic short-chain pineal bioregulator peptide, Epithalon is evaluated in preclinical models for its ability to induce telomerase expression, preserve chromosomal integrity, and regulate neuroendocrine output. PX1 Research provides high-purity research compounds backed by third-party HPLC and mass spectrometry testing strictly for in vitro and laboratory research applications.
In scientific literature and procurement contexts, searching for 'epithalon pharmacie' refers to the search for high-purity, pharmaceutical-grade Epithalon (also known as Epitalon) manufactured for quantitative laboratory research. Epithalon is a synthetic tetrapeptide comprised of the amino acid sequence L-alanyl-L-alpha-glutamyl-L-alpha-aspartyl-glycine (Ala-Glu-Asp-Gly). Originally derived from studies investigating pineal gland extracts (epithalamin), Epithalon was designed to replicate the biological signaling properties of endogenous pineal bioregulators while eliminating the heterogeneity inherent to tissue-extracted preparations.
When laboratory directors and researchers reference pharmaceutical-grade standards for this compound, the focus centers entirely on chemical identity, analytical purity, batch consistency, and freedom from biological contaminants. Authentic research-grade epithalon research peptide must exhibit exceptional sequence fidelity and minimal synthetic byproducts. Because Epithalon is evaluated in sensitive cellular and animal assays, small impurities can alter experimental outcomes or skew baseline telomerase measurements. Consequently, understanding the rigorous analytical specifications behind epithalon pharmacie standards is essential for generating reproducible data in longevity, epigenetic, and neuroendocrine research.
Epithalon functions within the broader class of peptide bioregulators—short amino acid chains capable of penetrating nuclear membranes and interacting directly with specific genomic regions. Preclinical studies suggest that short peptides like Ala-Glu-Asp-Gly bind to the promoter regions of genes, altering histones and modulating chromatin condensation states. By promoting a more open chromatin conformation (euchromatin), Epithalon enhances the transcriptional accessibility of specific genes responsible for cellular repair and maintenance.
In vitro data indicate that Epithalon interacts directly with DNA sequences, demonstrating a targeted affinity for specific nucleosome regions. This site-specific interaction is thought to activate suppressed genomic sequences without modifying the underlying genetic code. In somatic cell models, this non-mutagenic gene regulation leads to downstream changes in protein expression, particularly involving enzymes tied to genomic stability and cellular senescence. Researchers investigating gene expression profiles can explore related compounds within our comprehensive catalog of research peptides to compare transcriptional signaling cascades across different peptide classes.
The primary focus of Epithalon research involves its ability to induce telomerase activity—the ribonucleoprotein enzyme complex responsible for extending tandem hexanucleotide repeats (TTAGGG) at the terminal ends of eukaryotic chromosomes. During normal somatic cell division, the inability of DNA polymerase to fully replicate 5' ends results in progressive telomere shortening, eventually triggering the Hayflick limit and cellular senescence. Preclinical assays demonstrate that Epithalon application in human somatic cell cultures reactivates telomerase expression, thereby preserving telomere length across successive mitotic divisions.
In vitro studies utilizing human fibroblast models revealed that exposure to Epithalon resulted in a statistically significant increase in telomerase enzymatic activity compared to control groups. This enzymatic activation allowed cells to exceed their standard proliferative lifespan while maintaining normal karyotypic architecture without exhibiting malignant transformation. Furthermore, animal studies involving aging rodent models showed that long-term administration of Epithalon decreased chromosome aberration rates in bone marrow cells. Investigators seeking to examine the biochemical pathways underlying these cellular longevity responses can access detailed data in our review of epithalon telomerase activation mechanisms.
Beyond chromosomal maintenance, Epithalon exerts profound effects on pineal gland physiology and neuroendocrine homeostasis. The pineal gland plays a central role in regulating circadian rhythms via the pulsatile secretion of melatonin. As biological systems age, pineal involution typically results in a marked decline in nocturnal melatonin synthesis, leading to disrupted sleep architecture and altered neuroendocrine feedback loops.
Preclinical studies conducted in rodent and non-human primate models demonstrate that Epithalon restores nocturnal melatonin synthesis in aged pineal tissues. In elderly primate models, administration of Epithalon stimulated pineal sensitivity and normalized the diurnal rhythm of endogenous melatonin release to levels comparable to younger control subjects. In vitro assays suggest this effect is mediated by upregulating the expression of arylalkylamine N-acetyltransferase (AANAT)—the rate-limiting enzyme in melatonin biosynthesis. This dual role in both telomere preservation and neuroendocrine restoration positions Epithalon as a critical reference compound in systemic aging research.
To understand where Epithalon fits within experimental anti-aging and metabolic research, it is helpful to compare its mechanism against other leading preclinical compounds. While Epithalon primary targets nuclear DNA chromatin structure and telomerase expression, compounds like MOTS-c operate through mitochondrial-derived peptide pathways to regulate metabolic homeostasis and insulin sensitivity. Similarly, SS-31 (Elamipretide) targets cardiolipin within the inner mitochondrial membrane to mitigate electron transport chain reactive oxygen species (ROS) production, addressing oxidative stress at its organelle source rather than acting directly on nuclear telomere dynamics.
In contrast, targeted senolytic agents like FOXO4-DRI operate via apoptosis induction in senescent cells by disrupting the FOXO4-p53 interaction. Where FOXO4-DRI targets the clearance of non-dividing, senescent cell populations, Epithalon functions upstream by delaying the onset of senescence altogether through telomere preservation. Researchers designing comprehensive anti-aging paradigms frequently study these complementary classes side by side to evaluate multi-target intervention strategies.
When procuring material for research designated under epithalon pharmacie standards, rigorous chemical verification is non-negotiable. Pharmaceutical-grade standards require that every synthesized batch undergo dual-stage analytical testing: Reverse-Phase High-Performance Liquid Chromatography (RP-HPLC) for purity determination and Matrix-Assisted Laser Desorption/Ionization Time-of-Flight (MALDI-TOF) Mass Spectrometry for identity confirmation.
RP-HPLC analysis establishes peptide purity by separating the main target peak from minor synthetic impurities, such as truncated sequences or protective group adducts. A verified standard for research requires a main peak area integration of >98.0%. Mass spectrometry validates that the molecular weight precisely matches the theoretical mass of Epithalon (390.35 Da). Additionally, because bacterial lipopolysaccharides (LPS) can induce inflammatory cascades in cellular assays, material must undergo Chromogenic Recombinant Factor C (rFC) or LAL testing to confirm endotoxin levels below 0.1 EU/mg. Investigators can consult the PX1 research database for comprehensive technical overviews of analytical testing methodologies.
Proper handling and storage protocols are vital to maintain the structural stability of lyophylized Epithalon. Epithalon is supplied as a sterile, lyophilized cake to prevent hydrolytic degradation during storage. Upon receipt, lyophilized vials should be kept at -20°C or -80°C for long-term stability, protected from light and moisture.
Reconstitution should take place under sterile laminar flow conditions using an appropriate solvent. For general cell culture assays, sterile bacteriostatic water or phosphate-buffered saline (PBS, pH 7.4) is typically used. Researchers should gently swirl the vial rather than vigorously agitating the solution to avoid protein denaturation and mechanical shearing. Once reconstituted, liquid solutions should be aliquoted into single-use microcentrifuge tubes to avoid repeated freeze-thaw cycles, which degrade peptide integrity. Aliquots remain stable at 4°C for up to 7 days or at -20°C for up to 90 days. For step-by-step laboratory guidelines on preparing peptide solutions, refer to our complete peptide reconstitution protocols.
Procuring research compounds labeled with pharmaceutical-grade standards requires absolute transparency from the supplier. Overseas or unverified sources often lack batch-specific documentation, exposing laboratories to the risk of inconsistent purity, variable trifluoroacetic acid (TFA) salt content, or heavy metal contamination. PX1 Research eliminates these risks by strictly manufacturing and testing compounds in the USA within GMP-compliant, ISO 17025 accredited analytical facilities.
Every lot of Epithalon distributed by PX1 Research includes a batch-specific Certificate of Analysis (COA) accessible directly to researchers. This document details the exact RP-HPLC purity percentage, mass spectral confirmation, net peptide content, and quantified endotoxin limits. Furthermore, to accommodate high-volume laboratory requirements and institutional projects, PX1 Research provides dedicated support through our bulk laboratory accounts program. All orders ship directly from centralized fulfillment facilities in California and Arizona, offering same-day dispatch Monday through Friday to ensure uninterrupted research workflows.
What does 'epithalon pharmacie' signify in a laboratory context?
The term refers to pharmaceutical-grade chemical standards for Epithalon (Epitalon), characterized by >98% RP-HPLC purity, mass spectrometry identity confirmation, and low endotoxin levels required for rigorous preclinical research.
Is Epithalon approved for human clinical use or medical treatment?
No. Epithalon is strictly a research compound intended solely for in vitro, cell culture, and preclinical animal laboratory studies. It is not approved by the FDA or international regulatory bodies for human consumption, medical diagnosis, or therapeutic use.
What is the primary mechanism of action demonstrated by Epithalon in preclinical studies?
Preclinical studies show that Epithalon activates telomerase enzyme expression, promotes telomere elongation in somatic cells, restores pineal gland melatonin production, and interacts directly with DNA promoter regions to alter gene expression.
How is Epithalon purity verified by PX1 Research?
Every lot undergoes independent ISO 17025 laboratory testing utilizing Reverse-Phase High-Performance Liquid Chromatography (RP-HPLC) for purity verification and Mass Spectrometry (MS) for molecular weight confirmation. Endotoxin levels are also quantified via LAL/rFC assays.
What solvent should be used to reconstitute Epithalon for laboratory assays?
Epithalon is readily soluble in aqueous solutions. Depending on the assay parameters, laboratory researchers typically reconstitute the lyophilized powder using sterile bacteriostatic water or sterile phosphate-buffered saline (PBS, pH 7.4).
How should reconstituted Epithalon be stored in the laboratory?
Once reconstituted, liquid Epithalon should be divided into single-use aliquots to prevent freeze-thaw degradation. Aliquots can be stored at 4°C for short-term use (up to 7 days) or kept frozen at -20°C to -80°C for up to 90 days.
What is the theoretical molecular weight of Epithalon?
The theoretical molecular weight of Epithalon (Ala-Glu-Asp-Gly, molecular formula C14H22N4O9) is approximately 390.35 Da, which is verified via mass spectrometry during quality control.
How does Epithalon compare to mitochondrial peptides like MOTS-c?
Epithalon operates primarily in the nucleus to influence chromatin structure and induce telomerase activity, whereas MOTS-c is a mitochondrial-derived peptide that regulates metabolic gene expression, glucose homeostasis, and cellular energy pathways.
All products are sold strictly for laboratory and research use only. Not for human or veterinary use, diagnosis, treatment or consumption. Statements have not been evaluated by the FDA.